Verification
Every hospital and specialist in the CureSureMedico network is reviewed against structured criteria. Only providers that meet the network's requirements are offered to patients.
Provider Verification
Hospital and specialist identity, registration and relevant organisational information reviewed.
Accreditation & Credentials
Relevant accreditations (JCI, NABH, NABL and others) and specialist credentials verified where available.
Clinical Capability
Relevant specialties, procedures, clinical technologies and infrastructure assessed for the treatments the hospital supports.
International Patient Infrastructure
International patient departments, language support, visa assistance, accommodation coordination and interpreter services reviewed where applicable.
Ongoing Review
Partner status and relevant provider information reviewed on a periodic basis.
Clinical fit
CureSureMedico does not rank hospitals. Instead, the platform matches patients to providers based on their specific clinical requirement, treatment need, specialist expertise and destination preference.
Your need
Treatment
Who delivers it
Specialist
Where it happens
Hospital
Your destination
Country
The right hospital for your case depends on the treatment you need, the specialist who delivers it, and the clinical capabilities of the facility — not on a generic ranking.
Our clinical advisors review your medical history and recommend the most suitable specialist within our accredited network — at no cost to you.
24/7 Support
Direct access to clinical experts via WhatsApp.
Confidential Review
Your medical data is protected by HIPAA standards.
Response within 2 hours
A clinical advisor contacts you same day.
CureSureMedico coordinates access to clinical expertise and healthcare providers. CureSureMedico does not provide medical advice, make independent medical diagnoses, or replace the treating physician. Diagnosis and treatment decisions remain with qualified treating clinicians and healthcare institutions. Hospital information is based on available data and may change; verify details directly with the provider where necessary.
Explore CureSureMedico's verified hospital network by treatment, specialty, destination and clinical capability. Matched to your clinical requirement, not to availability.
250+
Partner Hospitals
10+
Countries
Certified Quality
Every facility individually vetted
Internationally Vetted
Clinical standard
Audited Quarterly
Success & outcomes
Vetted by our board
Clinical governance
Search & Filter
more than 250 hospitals foundAll Partners
more than 250 found
Beijing, China
Beijing GoBroad Boren Hospital, a flagship hospital of GoBroad Healthcare Group in Fengtai District, Beijing, specialises in haematologic malignancies — leukaemia, lymphoma, myeloma, aplastic anaemia, and thalassaemia — with dedicated CAR-T cell therapy and stem cell transplant programmes.
Beijing, China
Beijing Lu Daopei Hospital, part of the independent Lu Daopei Medical Group in the Beijing Economic-Technological Development Area, is named for academician Lu Daopei, widely regarded as the father of Chinese bone marrow transplantation. The group — one of the world's largest haematopoietic stem cell transplant networks, performing an estimated 10% of China's annual allogeneic transplant volume — completed its 10,000th transplant in April 2024, reportedly the fastest any centre has reached that milestone. The hospital specialises in leukaemia, lymphoma, and other blood cancers, alongside comprehensive stem cell transplantation care.
Beijing, China
Peking University People's Hospital opened in 1918 as Peking Central Hospital, the first general hospital in China to be entirely Chinese-financed and Chinese-run, and today serves as the Second Clinical Medical School of Peking University with over 2,600 beds and 1,300 physicians across its campuses. Its Institute of Hematology, established in 1981, is where academician Lu Daopei performed China's first successful allogeneic bone marrow transplant and has ranked first nationally in haematology for eleven consecutive years. The hospital's orthopaedics department, founded in 1944 by Feng Chuanhan — founder of the Chinese Orthopaedic Association — operates one of the largest bone tumour centres of its kind internationally.
1,300+
Specialists
2,600+
Beds
Shanghai, China
Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, was founded in 1907 and has grown into a leading Class 3A academic medical centre with close to 2,800 beds across three campuses in Shanghai. It is internationally recognised in haematology: physician-scientists at Ruijin — including Wang Zhenyi, Chen Zhu, and Chen Saijuan — developed the combined all-trans retinoic acid (ATRA) and arsenic trioxide therapy for acute promyelocytic leukaemia, raising five-year survival from roughly 10% to over 97% and reshaping leukaemia treatment worldwide. The hospital completed a DNV DIAS international accreditation audit in 2025, recognised by insurers in more than 130 countries, and also maintains strong programmes in endocrinology and minimally invasive gastrointestinal surgery.
DNV DIAS
Shanghai, China
Shanghai GoBroad Cancer Hospital, part of GoBroad Healthcare Group, opened in October 2023 in the Shanghai (Waigaoqiao) Free Trade Zone as the zone's first research-type hospital. The 406-bed Phase I facility (with a further expansion to roughly 700 beds planned by 2026) specialises in solid-tumour oncology, including digestive cancers, bone and soft-tissue sarcoma, and lung cancer, alongside cellular and targeted-therapy programmes.
406+
Beds
Shanghai, China
Shanghai Jiahui International Hospital opened in October 2017 in Xuhui District as a 500-bed JCI-accredited international hospital built on a strategic partnership with Massachusetts General Hospital (Mass General Brigham) and Harvard Medical School dating to 2012. More than 600 Jiahui staff have trained at MGH's Boston campus, and the Jiahui International Cancer Center operates as a joint programme with the MGH Cancer Center. The hospital also offers strong ENT, gastroenterology, and orthopaedic programmes for international patients.
JCI500+
Beds
Shanghai, China
Shanghai Tongji Hospital is a Class 3A teaching hospital affiliated with Tongji University School of Medicine, operating close to 1,300 beds across its Putuo District campus in Shanghai. It holds municipal top-priority discipline status in orthopaedics and in psychiatry and neurology, with additional recognised strengths in cardiology, spine surgery, psychosomatic medicine, and gastroenterology.
1,300+
Beds